Delivery Order 75A50122D00004-75A50126F61014

Award Date 9/30/26

Potential Completion Date 9/29/29

Potential Value $29M

Federal Agency

Office of the Assistant Secretary for Preparedness and Response

Awardee

Seqirus Inc. Z6N1LJ2RD6E3

Ultimate Awardee

Not listed

NAICS Category

325414 - Biological Product (except Diagnostic) Manufacturing

PSC Category

6505 - Drugs And Biologicals

Federal Contract Vehicle

Not listed

Set-Aside Type

No Set-Aside Used

Extent Competed

Full and Open Competition

Major Defense Program

Not listed

Pricing Type

Firm Fixed Price

Place of Performance

Holly Springs, NC, USA

Solicitation Procedures

Negotiated Proposal / Quote

Number Of Offers Received

Not listed

Legislative Mandate

Employment Eligibility Verification

National Interest Action

Not listed

Research Type

Not listed

Primary Consortia Member

Not listed

The Office of the Assistant Secretary for Preparedness and Response issued a delivery order to Seqirus Inc. on September 30, 2026, with a ceiling value of $28.689 million for manufacture and stability studies of thimerosal-free pandemic influenza vaccine multidose vials, under a firm fixed-price structure with an ultimate completion date of September 29, 2029.

Place of performance is Holly Springs, NC. The order calls for cGMP manufacturing of vaccine formulations, filling of multidose vials, and associated stability testing and storage of vaccine stockpiles. This delivery order is issued against Seqirus's parent Indefinite Delivery Contract with HHS ASPR, which carries a $13.4 billion ceiling and an ultimate completion date of February 21, 2027.

Generated 9/25/26, 9:45 AM